EMEA-003037-PIP01-21 - paediatric investigation plan
Decision type: RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
Therapeutic area: DiagnosticOncology
PIP number: P/0435/2021
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder and solvent for dispersion for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Scandonest and associated names - referral
mepivacaine
Article 30 referrals
Associated names:
Biocaine
Scandicaine
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Imagify
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-000194-PIP03-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Diagnostic
PIP number: P/116/2011
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Perflubutane - paediatric investigation plan
Decision type: RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
Therapeutic area: Cardiovascular diseases
PIP number: P/106/2008
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Lyophilisate for suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman